Drug "Sumamed ® " is applied at the infections caused by the microorganisms sensitive to azithromycin:
- ENT organs (bacterial pharyngitis / tonsillitis, sinusitis, average otitis);
- respiratory infection (bacterial bronchitis, community-acquired pneumonia);
- an infection of leather and soft tissues: the migrating erythema (initial stage of a disease of Lyme), an ugly face, impetigo, secondary pyodermatoses;
- an infection, sexually transmitted: the uncomplicated genital infections caused by Chlamydia trachomatis.
Structure
1 tablet contains 500 mg of azithromycin (active ingredient) in the form of dihydrate azithromycin.
Excipients: sodium saccharin dihydrate, cellulose microcrystalline, krospovidon (type A), povidone, sodium lauryl sulfate, silicon dioxide colloidal waterless, magnesium stearate, aspartame (E 951), fragrance orange.
Contraindication
Hypersensitivity to azithromycin, erythromycin, to any makrolidny or ketolidny antibiotic and also to any other component of medicine.
Route of administration
is Applied inside in 1 hour prior to or in 2 hours after meal. In case of the admission of reception of 1 dose of medicine it is necessary to accept the passed dose as soon as possible, and the subsequent - with an interval of 24 hours.
Tablet that is dispersed, is previously dissolved in not less than 50 ml of water. Before application carefully to stir the received suspension.
Adults and children are more senior than 12 years with body weight ≥ 45 kg.
In infections of ENT organs, airways, skin and soft tissues (except the chronic migrating erythema) the general dose of azithromycin makes 1500 mg (500 mg of 1 times a day). Duration of treatment is 3 days.
At the migrating erythema the general dose of azithromycin makes 3 g which should be accepted according to the following scheme: 1000 mg in the first day, then - on 500 mg of 1 times a day from the 2nd to the 5th day.
In infections, sexually transmitted , the recommended dose of azithromycin makes 1000 mg once.
Children of 3-12 years with body weight <45 kg.
In infections of ENT organs, airways, skin and soft tissues (except the chronic migrating erythema) azithromycin is applied at the rate of 10 mg/kg of body weight of 1 times a day within 3 days (the general dose of azithromycin makes 30 mg/kg).
Calculation of a dose for children with body weight <45 kg.
Body weight | an azithromycin Dose in mg |
18-30 kg | 250 mg |
31-44 kg | 375 mg |
not less than 45 kg | Dose recommended for adults |
to Children up to 3 years recommends to apply "Sumamed ® ", powder to oral suspension (100 mg / 5 ml), or "Sumamed ® forte", powder for oral suspension (200 mg / 5 ml). In pharyngitis/tonsillitis, caused Streptococcus pyogenes , medicine "Sumamed ® " apply in a dose 20 mg/kg/days within 3 days (course dose of 60 mg/kg). The maximum daily dose makes 500 mg/days
At the migrating erythema apply azithromycin at the rate of 20 mg/kg of 1 times a day in the first day then - 10 mg/kg of 1 times a day from the 2nd to the 5th day.
To convenience of application of a course dose of 60 mg/kg to children recommends to apply "Sumamed ® ", powder to oral suspension (100 mg / 5 ml), or "Sumamed ® forte", powder for oral suspension (200 mg / 5 ml).
Feature of application
Pregnant women
Are not present adequate data on use of azithromycin to pregnant women. In researches of reproductive toxicity at animals of a teratogenic adverse effect of azithromycin on a fruit it is noted, however medicine got through a placenta. Safety of use of azithromycin during pregnancy is not confirmed. Therefore azithromycin is appointed during pregnancy, only if the advantage exceeds risk.
toIt was reported, that azithromycin gets into breast milk, but corresponding and properly controlled clinical trials which would give the chance to characterize pharmacokinetics of excretion of azithromycin in breast milk, was not carried out.
Research of fertility was conducted on rats; the indicator of pregnancy decreased after administration of azithromycin. The relevance of these data on the person is unknown.
Drivers
Proof that azithromycin can worsen ability to steer motor transport or other mechanisms are absent, but it is necessary to consider a possibility of development of side reactions, such as dizziness, drowsiness, disorder of vision.
Overdose
Experience of clinical use of azithromycin demonstrates to what side effects which develop at reception of higher than is recommended, medicine doses, are similar to those that are observed at application of usual therapeutic doses. They can include diarrhea, nausea, vomiting, a reverse hearing loss. In case of overdose if necessary intake of activated carbon and performing the general symptomatic and supporting treatment is recommended.
Side reactions
are given byIn the following table the side reactions defined by clinical trials and in the period of post-marketing observation at application of all dosage forms of azithromycin. Side reactions are given on the systems of bodies and frequency. The undesirable reactions registered in the period of post-marketing observation are italicized. Frequency is determined as follows: very often (≥ 1/10); often (≥ 1/100 to <1/10); infrequently (≥ 1/1000 to <1/100); seldom (≥ 1/10000 to <1/1000), it is very rare (<1/10000); it is unknown (it is impossible to determine by the available data). Within each group on the frequency of manifestations the undesirable phenomena are noted as reduction of their weight.
Undesirable reactions which are possibly connected with azithromycin on the basis of the data obtained during clinical trials and during post-marketing observation.
Class of systems and bodies | to Undesirable reaction | to Frequency |
Infection and an invasion | to Candidiasis, oral candidiasis, vaginal infections, pneumonia, a fungal infection, a bacterial infection, pharyngitis, a gastroenteritis, breath dysfunction, rhinitis | to infrequently |
Pseudomembranous colitis | does not know to
| |
from blood and lymphatic system | Leukopenia, a neutropenia, an eosinophilia | infrequently |
Thrombocytopenia, hemolytic anemia | is unknown | |
from the immune system | Quincke's disease, reaction of hypersensitivity | to infrequently |
Anaphylactic reaction | does not know to
| |
from a metabolism | Anorexia | infrequently |
from mentality | Nervousness, insomnia | infrequently |
Agitation | is rare | |
Aggression, concern, a delirium, hallucinations | does not know to
| |
from nervous system | Headache | is frequent |
Dizziness, drowsiness, a dysgeusia, paresthesias | infrequently | |
Faint, spasms, a hypesthesia, psychomotor superactivity, an anosmia, an ageusia, a parosmiya, a myasthenia gravis | does not know to
| |
from organs of sight | Disorder of vision | infrequently |
from organs of hearing | Disorder from organs of hearing, vertigo | infrequently |
Hearing disorder, including deafness and/or a ring in ears | does not know to
| |
from heart | Palpitation | infrequently |
Trembling fibrillation of ventricles (torsade de pointes), arrhythmia, including ventricular tachycardia, | to does not know lengthening of a QT interval on the ECG | |
from vessels | Inflows | infrequently |
Arterial hypotension | is unknown | |
from a respiratory system | Dispnoe, nasal bleeding | infrequently |
from a digestive tract | Diarrhea | is very frequent
|
Vomiting, an abdominal pain, nausea | it is frequent | |
Constipation, a meteorism, dyspepsia, gastritis, a dysphagy, dryness in a mouth, an eructation, ulcers in an oral cavity, saliva hypersecretion | to infrequently | |
Pancreatitis, discoloration of language | does not know to
| |
from a gepatobiliarny system | Abnormal liver function, cholestatic jaundice | it is rare |
Liver failure (which seldom led to a lethal outcome), fulminantny hepatitis, necrotic hepatitis | is unknown | |
from skin and hypodermic cellulose | Rash, an itch, urticaria, dermatitis, xeroderma, a hyperhidrosis infrequently | |
Photosensitivity, sharp generalized exanthematous pustulyoz | is rare |
|
Stephens-Johnson's Syndrome, a toxic epidermal necrolysis, a polymorphic erythema, reaction to medicine with an eosinophilia and system symptoms | is unknown | |
from a musculoskeletal system | Osteoarthritis, myalgia, a dorsodynia, neck pain | infrequently |
Arthralgia | is unknown | |
from an urinary system | Dysuria, kidney pain | infrequently |
Acute renal failure, interstitial nephrite | is unknown | |
from a reproductive system and mammary glands | Uterine bleeding, testicular violations | infrequently |
General violations and local reactions | Hypostasis, an adynamy, an indisposition, fatigue, a face edema, a stethalgia, a hyperthermia, pain, peripheral hypostasis | infrequently |
Laboratory indicators | Lowered quantity of lymphocytes, the increased quantity of eosinophils, reduced level of bicarbonate of blood, increase in level of basophiles, increase in level of monocytes, increase in level of neutrophils | is frequent |
Raised the AsAT level, raised the AlAT level, raised bilirubin level in blood, raised urea level in blood, raised creatinine level in blood, changes of indicators of potassium in blood, increase in level of alkaline phosphatase, increase in level of chloride, increase in level of glucose, increase in level of platelets, decrease in level of a hematocrit, increase in level of bicarbonate, a sodium level deviation | infrequently | |
Defeat and poisoning | Complication after the procedure | infrequently |
Information on side effects which, perhaps, are connected with prevention and treatment Mycobacterium Avium Complex , is based on data of clinical trials and observations during the post-marketing period. These undesirable reactions differ on type or on frequency from about what it was reported at application of high-speed dosage forms and dosage forms of long action.
Undesirable reactions which are perhaps connected with prevention and treatment of Mycobacterium Avium Complex.
Class of systems and bodies | Undesirable reaction | Frequency |
from a metabolism | Anorexia | it is frequent |
from nervous system | Dizziness, a headache, paresthesias, a dysgeusia | is frequent |
Hypesthesia | infrequently | |
from organs of sight | Disorder of vision | is frequent |
from organs of hearing | Deafness | is frequent |
Hearing disorder, a ring in ears | infrequently | |
from heart | Palpitation | infrequently |
from a digestive tract | Diarrhea, an abdominal pain, nausea, a meteorism, gastrointestinal discomfort, a frequent liquid chair | is very frequent |
from digestive system | Hepatitis | infrequently |
from skin and hypodermic cellulose | Rash, an itch is frequent |
|
Stephens-Johnson's Syndrome, photosensitivity | infrequently | |
from a musculoskeletal system | Arthralgia | is frequent |
General violations and local reactions | Increased fatigue | is frequent |
Asthenia, an indisposition | infrequently | |
Storage conditions
Drug does not demand special storage conditions. To store out of children's reach.
Expiration date - 2 years.
Characteristics | |
Active ingredients | Azithromycin |
Amount of active ingredient | 500 mg |
Applicant | Teva |
Code of automatic telephone exchange | J01FA10 Azithromycin |
Interaction with food | To |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | D.O.O. PLIVA HRVATSKA. |
Quantity in packing | 6 tablets |
Release form | tablets for internal use dispersed |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Sumamed |
Sumamed of the tab. disperg. 500 mg No. 6
- Product Code: 179582
- In Stock
- Ready to ship
-
$59.33